A new study, conducted on mice, has shown that a drug used in a type of hereditary metabolic disorder could improve the memory of people suffering from Alzheimers disease.
Researchers of the Center for Applied Medical Research (CIMA) of the University of Navarra have shown that the drug sodium phenylbutyrate, prescribed until now for patients with alterations in the urea cycle, eases the fusion of proteins responsible for neuron connections, thus increasing the learning capacity of the mice involved.
Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Dr. Ana Garcia-Osta, principal author of the study, said that these findings also provide a new alternative to the drugs that are currently available for fighting this devastating disease.
The research team is currently focused on discovering the acting mechanism in this drug.
Brilliant Human Brain
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
The study is published in the journal Neuropsychopharmacology.
Advertisement
SRM
Alzheimer's, Dementia Can Run in Families: Study
A team researchers at Boston University School of Medicine (BUSM) has found that people who have parents diagnosed with Alzheimer's disease or dementia are significantly more likely
A team researchers at Boston University School of Medicine (BUSM) has found that people who have parents diagnosed with Alzheimer's disease or dementia are significantly more likely
